Semaphorins and their receptors play crucial roles not only in axon guidance during neuronal development but also in the regulation of immune responses. Plexin-A4, a member of the plexin-A subfamily, forms a receptor complex with neuropilins and transduces signals for class III semaphorins in the nervous system. Although plexin-A4 is also expressed in the lymphoid tissues, the involvement of plexin-A4 in immune responses remains unknown. To explore the role of plexin-A4 in the immune system, we analyzed immune responses in plexin-A4-deficient (plexin-A42/2) mice. Among immune cells, plexin-A4 mRNA was detected in T cells, dendritic cells and macrophages but not in B cells and NK cells. Plexin-A42/2 mice had normal numbers and cell surface markers for each lymphocyte subset, suggesting that plexin-A4 is not essential for lymphocyte development. However, plexin-A42/2 mice exhibited enhanced antigen-specific T cell responses and heightened sensitivity to experimental autoimmune encephalomyelitis. Plexin-A42/2 T cells exhibited hyperproliferative responses to anti-CD3 stimulation and to allogeneic dendritic cells in vitro. Furthermore, this hyperproliferation was also observed in both T cells from neuropilin-1 mutant (npn-1 Sema2 ) mice, in which the binding site of class III semaphorins is disrupted, and T cells from Sema3A-deficient (Sema-3A2/2) mice. Collectively, these results suggest that plexin-A4, as a component of the receptor complex for class III semaphorins, negatively regulates T cell-mediated immune responses.
Introduction
Semaphorins are a family of secreted and transmembrane proteins characterized by a conserved amino terminal 'Sema domain' (1) . Although they were originally identified as axon guidance factors during neuronal development (2-4), semaphorins have also been shown to have diverse and important physiological and pathological roles in cardiovascular development, tumor progression and immune regulation (5) (6) (7) (8) (9) . A number of studies with gene-targeted mice have shown that some of membrane-bound semaphorins such as Sema4A, Sema4D, Sema6D and Sema7A are critically involved in immune regulation (10) (11) (12) (13) (14) (15) . In addition, it was recently reported that a secreted semaphorin, Sema3A, is involved in T cell regulation (16, 17) .
In the nervous system, neuropilin and plexin molecules serve as the major semaphorins receptors (18, 19) . In particular, plexins are critical for the transduction of semaphorins signals. Plexins can be dividied structurally into four classes: plexin-A1-A4, plexin-B1-B3, plexin-C and plexin-D. Plexin-A not only forms a receptor complex with neuropilins for secreted class III semaphorins but also binds directly to transmembrane class VI semaphorins in a neuropilin-independent manner (20) (21) (22) . Plexin-B1 directly binds to a class IV semaphorin, Sema4D (23) . Plexin-C1 has been reported to interact with the class VII semaphorin, Sema7A (23) . Plexin-D1 has been shown to bind class III semaphorins in both a neuropilin-independent and -dependent manner (24, 25) . In the immune system, plexin-A1 has been reported to be critically involved in dendritic cell (DC) functions (14) . Indeed, plexin-A1À/À mice display severely impaired T cell responses because of defective DC functions. Although Sema6D, a class VI semaphorin, can bind to wild-type DCs and induce IL-12 production, both Sema6D binding and Sema6D-induced IL-12 production are severely impaired in plexin-A1À/À DCs, indicating that plexin-A1 is a Sema6D receptor in the immune system. In addition to plexin-A1, other plexin molecules are expressed on various cells in the immune system. However, aside from plexin-A1, the immunological functions of other plexins are largely unknown.
In the present study, we analyzed immune responses in plexin-A4À/À mice. Plexin-A4À/À mice exhibit significantly elevated T cell responses in vivo and develop exacerbated experimental autoimmune encephalomyelitis (EAE) when immunized with myelin oligodendrocyte glycoprotein (MOG)-derived peptides. T cells from plexin-A4À/À mice as well as mice lacking class III semaphorins signaling show enhanced responses when stimulated with anti-CD3 or allogeneic DCs. Thus, plexin-A4 appears to function as a negative regulator of T cell responses.
Methods

Mice
C57BL/6 and BALB/c mice were purchased from Clea. Plexin-A4À/À(21), neuropilin-1 mutant (npn-1 SemaÀ ) (26), Sema3AÀ/À (27) and Sema6AÀ/À (28) mice on a C57BL/6 background were generated as previously described. All mice used in this study were maintained in a specific pathogenfree environment. All animal experimental procedures were consistent with our institutional guidelines.
Antibodies
For flow cytometry, mouse thymocytes and splenocytes were stained in the presence of Fc block (anti-CD16/32, 2.4G2) with the following antibodies: anti-CD4 (GK1.5), anti-CD8a (53-6.7), anti-B220 (RA-6B2), anti-CD3 (2C11), anti-CD11c (HL3), anti-CD11b (M1/70), anti-F4/80 (CI:A3-1), anti-Pan NK (DX5), anti-CD40 (3/23), anti-CD80 (16-10A1), anti-CD86 (GL-1) and anti-I-A b (25-9-17) conjugated with FITC, PE or allophycocyanine in the presence of Fc block. All these antibodies, except for anti-F4/80 (Serotec), were purchased from BD PharMingen.
Reverse transcription-PCR
Reverse transcription (RT)-PCR was performed with 35 cycles of 94°C for 30 s, 60°C for 30 s and 72°C for 30 s using the primers 5#-GATGAGTCTGCCCTGTGCATCTTC-3# and 5#-AAGGCCAGTGAGTGGTTCTTGTAG-TAG-3#. For real-time RT-PCR analysis, RNA was isolated from B cells, T cells, DCs, macrophages and NK cells using RNeasy kits (Qiagen, Hilden, Germany) and treated with DNase I (Invitrogen, Carlsbad, CA, USA) to eliminate genomic DNA. cDNA was synthesized using a SuperScript II cDNA synthesis kit (Invitrogen).
In vivo T cell priming
For keyhole limpet hemocyanin (KLH)-specific T cell priming, mice were immunized in the hind footpad with 10 lg of KLH emulsified in CFA (Sigma). Five days after immunization, CD4
+ T cells were isolated from the draining lymph nodes by magnetic cell sorting (MACS; Miltenyi Biotech, Bergisch Gladbach, Germany), and 5 
Induction of EAE
On day 0, mice were injected subcutaneously in both flanks with the 100 lg of MOG 33-35 peptide emulsified in CFA. The mice received 100 ng of pertussis toxin intravenously (List Laboratories) on days 0 and 2. All mice were monitored daily for clinical signs and were scored using a scale of 0-4 as follows: 0, no overt signs of diseases; 1, limp tail; 2, complete hind limb paralysis; 3, complete forelimb paralysis and 4, moribund state or death. For passive EAE experiments, donor mice were immunized with MOG/CFA in the same fashion as when inducing EAE, but no pertussis toxin was administered. Spleens and draining lymph nodes were collected 10 days later, single-cell suspensions were prepared, and RBCs were lysed. Cells (6 3 10 6 cells per ml) were cultured in RPMI1640 medium with 40 lg ml À1 of MOG 35-55 peptide and 10 ng ml À1 of recombinant mouse IL-12 (R&D Systems). After 3 days of culture, cells were harvested and T cells were isolated by negative selection using Dynabeads (Invitrogen). Recipient mice were irradiated sublethally (500 cGy) and received 5 3 10 6 cells intravenously.
In vitro assay CD4 + T cells and splenic DCs were isolated from the spleen using MACS, with >95% purity in each experiment. Bone marrow-derived dendritic cells (BMDCs) were generated from bone marrow progenitors using granulocyte macrophage colony-stimulating factor as previously described (29) . For T cell proliferation assays, CD4
+ cells ( 
Immunoblotting and Ca2
+ mobilization
For immunoblotting analysis, Thy1.2 + cells (2 3 10 6 cells) were seeded into 24-well plates coated with anti-CD3 (1 lg ml À1 ) for the indicated times. Cells were solubilized in buffer containing 1% Nonidet-P40, 10 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 10 mM Na 3 VO 4 , 0.5 mM phenylmethylsulphonylfluoride and a phosphatase inhibitor cocktail (Calbiochem). Whole-cell lysates were separated by SDS-PAGE and immunoblotted with anti-phospho-Zap-70, anti-Zap-70, anti-Lat, anti-phospho-extracellular signal-regulated kinase (ERK), anti-ERK, anti-phospho-c-Jun N-terminal kinase (Jnk), anti-phospho-p38, anti-p38, anti-phospho-PLC-c1 or anti-PLC-c1 purchased from Cell Signaling Technology. For Ca 2+ mobilization analysis, purified T cells were loaded with 2 lM Fura-2 (Molecular Probes) for 15 min at 37°C. Cells were then washed with loading buffer and stimulated with biotinylated anti-CD3, and then cross-linked with streptavidin.
Results and discussion
Normal lymphoid development in plexin-A4À/À mice
The plexin-A4 expression profile in various mouse tissues was examined by RT-PCR. Plexin-A4 was found to be expressed in a broad range of tissues, including the brain, kidney, lung, heart, liver and spleen of adult mice and embryos Because plexin-A4 expression in particular immune cells subsets implied a role for plexin-A4 in the immune system, we analyzed the immunological phenotype of plexin-A4À/À mice. We first analyzed thymocytes and splenocytes by flow cytometry to determine if the absence of plexin-A4-expression affected lymphocyte development. The absence of plexin-A4 did not alter ratios of CD4 + and CD8 + thymocytes (Supplementary Figure 2A , available at International Immunology online). There were no differences in the expression of cell surface phenotype markers, and the ratios of T cells, B cells, macrophages, DCs and NK cells in the spleen were comparable between wild-type and plexin-A4À/À mice (Supplementary Figure 2B , available at International Immunology online). Additionally, regulatory T cells (CD4 + CD25 + or CD4 + Foxp3 + ) and memory T cells (CD4 + CD44 + ) populations were normal in plexin-A4À/À mice (Supplementary Figure 2C , available at International Immunology online). These findings indicate that plexin-A4 is not essential for lymphocyte development.
Plexin-A4À/À mice displayed enhanced in vivo T cell priming and exacerbated T cell-mediated autoimmunity Since higher plexin-A4 expression in T cells and DCs suggests that plexin-A4 plays a role in T cell activation, we immunized wild-type and plexin-A4À/À mice with KLH in CFA.
Five days after immunization, CD4
+ T cells were purified from the draining lymph nodes and restimulated with KLH in the presence of wild-type antigen-presenting cells (APCs). Both CD4 + T cells proliferation and cytokine production were enhanced in plexin-A4À/À mice compared with wild-type mice (Fig. 1) . We also immunized plexin-A4À/À mice with MOG peptide to induce EAE, a mouse model of multiple sclerosis. Clinical analysis revealed that plexin-A4À/À mice developed much more severe forelimbs and hind limbs paralysis than wild-type mice ( Fig. 2A) . Histological analyses showed a higher number of infiltrating mononuclear cells in the spinal cords of diseased plexin-A4À/À mice than wild-type mice (Fig. 2B) . To determine the contribution of plexin-A4 to MOG-specific T cell generation, T cells were isolated from the draining lymph nodes of immunized mice and restimulated with MOG peptide presented by syngeneic splenocytes. Plexin-A4À/À T cells had augmented proliferative (Fig. 2C) .
Plexin-A4 is known to function as an axon guidance factor in the nervous system (20, 21, 28) . Indeed, plexin-A4À/À mice display abnormal projection of hippocampal mossy fibers (21) . We then transferred T cells from MOG-immunized wild-type or plexin-A4À/À mice into wild-type recipients. Mice that received wild-type T cells developed a mild, transient EAE and recovered shortly after the acute episode (Fig. 2D) . In contrast, mice that received plexin-A4À/À T cells developed early onset, severer EAE with chronic and persistent disease (Fig. 2D) . These findings suggest that hyperactivation of MOG-specific T cells caused by a plexin-A4 deficiency in immune cells is primarily responsible for exacerbated EAE in plexin-A4À/À mice.
Plexin-A4À/À T cells were hyperproliferative in vitro
To elucidate the mechanism underlying the in vivo hyperactivation of plexin-A4À/À T cells, we next examined whether plexin-A4 deficiency affected in vitro T cell proliferation. Plexin-A4À/À T cells displayed higher proliferative responses than wild-type T cells after stimulation with a low concentration of anti-CD3 (0.1 lg ml À1 ) (Fig. 3A, left) . When examined kinetically, plexin-A4À/À T cells had enhanced proliferation at all time points (Fig. 3A, right) . We also examined the effect of plexin-A4 deficiency on proliferative Cytokines in the culture supernatants were measured using Bio-Plex suspension array systems (Bio-Rad). Data are the mean 6 SD of triplicate wells and are representative of two independent experiments. *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001; each value was analyzed by a Student's t-test. responses of T cells stimulated with antigens presented by APCs in an MLR. The responses of plexin-A4À/À T cells to allogeneic DCs were significantly higher than those of wild-type T cells (Fig. 3B) . It is also noteworthy that the ability of plexin-A4À/À DCs to stimulate allogeneic CD4 + T cell proliferation was stronger than that of wild-type DCs when plexin-A4À/À DCs were used as stimulators in an MLR (Fig. 3C) . However, we did not observe any differences in MHC class II expression, costimulatory molecule expression or IL-12 production between plexin-A4À/À and wild-type DCs after anti-CD40 or LPS stimulation ( Fig. 3D and E) , indicating that the enhanced allostimulatory activity of plexin-A4À/À DCs cannot be simply explained by an alteration in the expression of costimulatory molecules or cytokines.
Our findings indicate that a plexin-A4 deficiency in either T cells or DCs can enhance T cell activation, although the absence of T cells appears to have a greater impact. (Fig. 1B) . These results indicate that plexin-A4 expression in both T cells and DCs plays a role in negatively regulating T cell activation.
Partially enhanced TCR signals in plexin-A4À/À T cells
We then examined TCR signaling in plexin-A4À/À T cells. Anti-CD3-stimulated plexin-A4À/À and wild-type T cells were analyzed for phosphorylation of signaling molecules downstream of the TCR. Anti-CD3 stimulation enhanced phosphorylation of both Zap-70 and Lat in plexin-A4À/À T cells (Fig. 4A) . However, there were no significant differences in the phosphorylation of other signal molecules, such as ERK, Jnk, p38 and PLC-c1, between plexin-A4À/À and wild-type T cells (Fig. 4B) . Consistent with the observation that the plexin-A4 deficiency did not affect PLC-c1, the anti-CD3-induced calcium response was comparable between wildtype and plexin-A4À/À T cells (Fig. 4C) . Thus, plexin-A4 deficiency appears to affect some TCR signals directly or indirectly, although it remains unclear whether this alteration in TCR signaling is responsible for the hyperreactivity of plexin-A4À/À T cells.
Possible involvement of class III semaphorins in T cell responses as plexin-A4 ligands
Our observations with plexin-A4À/À mice suggested that plexin-A4 negatively regulates T cell activation; however, the plexin-A4 ligands in the immune system are unknown. Plexin-A4 and neuropilin-1 are known to form a receptor for Sema3A, a class III semaphorin, in the nervous system (21, 30) . In addition, plexin-A4 directly interacts with the transmembrane semaphorin, Sema6A (21, 22) . Therefore, we examined T cells from mice with defective class III semaphorin signaling. We first examined T cells from npn-1 SemaÀ mice, in which the binding site of class III semaphorins is disrupted. Npn-1 SemaÀ T cells showed enhanced responses to anti-CD3 stimulation (Fig. 5A ) and allogeneic DCs (Fig. 5B) , as observed in plexin-A4À/À T cells (Fig. 3A and B) . Sema3AÀ/À T cells, which have defective Sema3A production, were also slightly hyperproliferative in response to stimulation with anti-CD3 (Fig. 5C ) and allogeneic DCs (Fig. 5D) . In addition to class III semaphorins, a transmembrane semaphorin, Sema6A, is also known to directly interact with plexin-A4 (21, 22) . However, we could not detect any difference in T cell activation between Sema6AÀ/À mice and wild-type mice (Fig. 5E and F) . These results indicate that plexin-A4, as a receptor for class III semaphorins such as Sema3A, plays a role in negatively regulating T cell proliferation and activation. Consistent with these findings, it was recently reported that Sema3A produced by tumor cells or by T cells and DCs suppressed T cell activation (16, 17) . However, it remains unclear if Sema3A is the only class III semaphorin that negatively regulates T cells through plexin-A4, as Sema3A deficiency had less effect on T cells than a plexin-A4 deficiency or neuropilin-1 mutation. In addition to plexin-A4, plexin-A1 is also a signal transducer for class III semaphorins (31) . However, the phenotype of plexin-A1À/À mice is completely different from those of plexin-A4À/À, npn-1
SemaÀ and Sema3AÀ/À mice (14) . Furthermore, unlike plexin-A4À/À mice, plexin-A1À/À mice showed defective T cell responses. Collectively, plexin-A4 appears to be a major signaling transducer of class III semaphorins in T cells, although we cannot completely exclude a possibility that plexin-A4-independent mechanisms may be involved in the enhanced T cell responses in npn-1
SemaÀ and Sema3AÀ/À mice. We observed enhanced phosphorylation of some signaling molecules such as Zap-70 and Lat in plexin-A4À/À T cells; however, it is still unknown if plexin-A4 directly modulates TCR signals. It is also unclear how the activation of Zap-70 and Lat is selectively affected in the absence of plexin-A4. In the nervous system, class III semaphorins regulate the actin cytoskeleton and integrins to exert chemorepulsive activities on neuronal axons (32, 33) . It is possible that a similar mechanism may underlie plexin-A4-mediated T cell regulation. Further studies will clarify not only the detailed molecular mechanism by which plexin-A4 regulates T cells but + T cells purified from wild-type (closed circles) or Sema6AÀ/À (open circles) mice were cultured with irradiated allogeneic BMDCs for 72 h. Data are the mean 6 SD of triplicate wells and are representative of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001; each value was analyzed by a Student's t-test.
also the physiological and pathological significance in T cell immunity. 
